Review of automated insulin delivery systems for Type 1 diabetes and associated time in range outcomes
doi: 10.1186/s13578-021-00709-y
According to Good Life Family Medicine, semaglutide is the first FDA-approved drug since 2014 for chronic weight management in overweight or obese adults
UK Medical Guide Weight loss injections, particularly glucagon-like peptide-1 (GLP-1) receptor agonists such as semaglutide (Wegovy) and liraglutide (Saxenda), can cause dizziness in some individuals
Managing insulin resistance is important for reducing the risk of complications associated with type 2 diabetes and cardiovascular disease.Insulin resistance can affect the balance of several hormones in the body, which can contribute to a range of health issues
The field moved from single GLP-1 receptor agonism, to dual GIP/GLP-1 agonism, and then to adding a third receptor glucagon to capture an energy-expenditure lever on top of appetite and glucose control